These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6277111)

  • 1. [Cultivation of Bordetella pertussis in liquid semisynthetic nutrient media with ion-exchange resins].
    Sukhinova EE; Shmeleva EI; Mertsalova NU; Iulin II; Golshmid VK
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):64-7. PubMed ID: 6277111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of toxin of phase I Hemophilus pertussis in the medium added with anion exchange resin and mouse protection test of culture supernate.
    KUWAJIMA Y; MATSUI T; ASANO A
    Yokohama Med Bull; 1955 Dec; 6(6):375-91. PubMed ID: 13338325
    [No Abstract]   [Full Text] [Related]  

  • 3. The growth-supporting effect of some anion exchange resins for phase I Haemophilus pertussis.
    KUWAJIMA Y; MATSUI T; KISHIGAMI M
    J Hyg Epidemiol Microbiol Immunol; 1958; 2(1):16-22. PubMed ID: 13598891
    [No Abstract]   [Full Text] [Related]  

  • 4. The growth-supporting effect of some anion exchange resins for phase I Haemophilus pertussis.
    KUWAJIMA Y; MATSUI T; KISHIGAMI M
    Jpn J Microbiol; 1957 Oct; 1(4):375-81. PubMed ID: 13562972
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bordetella pertussis agglutinogens in cultivation dynamics].
    Basnak'ian IA; Aleksakhina NN; Shelemekh OV; Miriasova LV; Siundiukova RA
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (3):37-42. PubMed ID: 17672129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Improved technology of culturing Bordetella pertussis based on a study of the kinetics of the process].
    Miriasova LV; Basnak'ian IA
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Oct; (10):20-5. PubMed ID: 6318479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparative analysis of the antigenic complexes isolated from synthetic and semisynthetic media for the cultivation of Bordetella pertussis].
    Semina IE; Bazhanova IG; Melikhov VI; Chechot VA; Mileĭkovskaia MM; Mertsalova NU; Shmeleva EI; Remova TN; Sukhinova EE; Ozeretskovskaia MN
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (2):87-92. PubMed ID: 7653146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antigenic activity of Bordetella pertussis during cultivation in liquid nutrient media].
    Miriasova LV; Moshiashvili IIa; Basnak'ian IA; Sergeev VV; Zaporozhtsev LN
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jun; (6):31-6. PubMed ID: 209647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The development of a process for culturing Bordetella pertussis immobilized on a polyurethane carrier].
    Miriasova LV; Basnak'ian IA; Kopaeva TV; Sarkisov IIu
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):6-9. PubMed ID: 10851980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Extraction of the soluble antigens of B. pertussis during cultivation in a fluid nutrient medium].
    Igonina IuA; Trofimova NP
    Zh Mikrobiol Epidemiol Immunobiol; 1969 May; 46(5):133-4. PubMed ID: 4308061
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of surface antigens in the protective potency of Bordetella pertussis suspensions as measured by the intracerebral challenge technique in mice.
    Holt LB; Spasojevíc V
    J Med Microbiol; 1968 Aug; 1(1):119-26. PubMed ID: 4318938
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of hydromechanical stress on cellular antigens of Bordetella pertussis.
    Rodriguez ME; Hozbor DF; Yantorno OM
    J Ind Microbiol; 1996 Jul; 17(1):53-5. PubMed ID: 8987690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and preliminary immunobiological characterization of a novel, non-reverting, intranasal live attenuated whooping cough vaccine candidate.
    Cornford-Nairns R; Daggard G; Mukkur T
    J Microbiol Biotechnol; 2012 Jun; 22(6):856-65. PubMed ID: 22573165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Engineering of attenuated Bordetella pertussis bacteria producing immunogenic non-toxic form of pertussis toxin].
    Siniashina LN; Nechaeva EV; Amelina IP; Karataev GI
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (6):89-94. PubMed ID: 20095432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough.
    Bouchez V; Guiso N
    Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26242280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating pertussis toxin and its impact on vaccination.
    Coutte L; Locht C
    Future Microbiol; 2015; 10(2):241-54. PubMed ID: 25689536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interface between medicinal bacteriology and agricultural chemistry--innovation of culturing technology of Bordetella pertussis by a cyclodextrin derivative].
    Suzuki Y
    Nihon Saikingaku Zasshi; 1999 Nov; 54(4):833-9. PubMed ID: 10643300
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on culture conditions of Bordetella pertussis and relationship to immunogenicity of vaccines.
    Bellalou J; Relyveld EH
    Ann Microbiol (Paris); 1984; 135B(1):101-10. PubMed ID: 6095715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuated Bordetella pertussis: new live vaccines for intranasal immunisation.
    Mielcarek N; Debrie AS; Raze D; Quatannens J; Engle J; Goldman WE; Locht C
    Vaccine; 2006 Apr; 24 Suppl 2():S2-54-5. PubMed ID: 16823926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological activities of pertussigen from Bordetella pertussis strains of various agglutinogen types.
    Watanabe M
    Microbiol Immunol; 1984; 28(5):509-15. PubMed ID: 6088952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.